Drug Shortage Report for DEPO-PROVERA

Last updated on 2019-04-17 History
Report ID 79397
Drug Identification Number 00585092
Brand name DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name Depo-Provera
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MEDROXYPROGESTERONE ACETATE
Strength(s) 150MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 5x1ml
ATC code G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-03-25
Estimated end date 2019-04-16
Actual end date 2019-04-16
Shortage status Resolved
Updated date 2019-04-17
Company comments Other presentation available: Depo-Provera 150mg/ml 1x1ml
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-04-17 English Compare
v7 2019-04-16 French Compare
v6 2019-04-16 English Compare
v5 2019-04-11 French Compare
v4 2019-04-11 English Compare
v3 2019-03-26 English Compare
v2 2019-03-25 French Compare
v1 2019-03-25 English Compare

Showing 1 to 8 of 8